Alexander J Denner's Net Worth

$12.7 Million

Estimate Recalculated Nov 8, 2024 09:31PM EST

Who is Alexander J Denner

Alexander J Denner has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., ENZON PHARMACEUTICALS INC, Iterum Therapeutics plc, ADVENTRX PHARMACEUTICALS INC, APRICUS BIOSCIENCES, INC., Regulus Therapeutics Inc., Bioverativ Inc., Innoviva, Inc., ARIAD PHARMACEUTICALS INC, AMYLIN PHARMACEUTICALS INC, VIVUS INC, MEDICINES CO /DE, and IMCLONE SYSTEMS INC.

SEC CIK

Alexander J Denner's CIK is 0001361754

Past Insider Trading and Trends

2011 was Alexander J Denner's most active year for acquiring shares with 9 total transactions. Alexander J Denner's most active month to acquire stocks was the month of May. 2013 was Alexander J Denner's most active year for disposing of shares, totalling 13 transactions. Alexander J Denner's most active month to dispose stocks was the month of April. 2013 saw Alexander J Denner paying a total of $2,189,294.25 for 107,538 shares, this is the most they've acquired in one year. In 2013 Alexander J Denner cashed out on 81,850 shares for a total of $9,750,497.35, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN IDEC INC.

Investor
Updated Jun 17, 2022
Form 4
9.98%
1.37K
Jun 17, 2022
658.10K
Grant
Jun 15
Form 4
5.98%
775.00
Jul 02, 2021
656.73K
Grant
Jul 01
Form 4
7.38%
890.00
Jun 05, 2020
655.95K
Grant
Jun 03
Form 4
10.59%
1.16K
Jun 20, 2019
655.06K
Grant
Jun 19
Form 4
22.56%
118.34K
$229.94
$27.21M
May 02, 2019
653.91K
Purchase
Apr 30 - May 02
Form 4
13.60%
62.80K
$327.59
$20.57M
Feb 01, 2019
535.57K
Purchase
Jan 30 - Feb 01
Form 4
8.77%
880.00
Jun 14, 2018
472.77K
Grant
Jun 12
Form 4
11.60%
48.00K
$269.91
$12.96M
Apr 27, 2018
471.89K
Purchase
Apr 25
Form 4
7.82%
30.00K
$317.36
$9.52M
Nov 30, 2017
423.89K
Purchase
Nov 28 - Nov 29
Form 4
0.24%
933.00
$316.56
$295.35K
Aug 31, 2017
393.89K
Grant
Aug 31
Form 4
11.76%
1.05K
Jun 09, 2017
393.89K
Grant
Jun 07
Form 4
23.83%
73.86K
$278.50
$20.57M
May 01, 2017
392.83K
Purchase
Apr 27
Form 4
13.43%
1.06K
Jun 09, 2016
318.95K
Grant
Jun 08
Form 4
310.00K
$277.47
$86.02M
Oct 26, 2015
317.89K
Purchase
Oct 22 - Oct 23
Form 4
9.66%
695.00
Jun 11, 2015
7.89K
Grant
Jun 10
Form 4
13.75%
870.00
Jun 16, 2014
7.20K
Grant
Jun 12
Form 4
-31.44%
-2.90K
$212.00
-$614.80K
Jun 17, 2013
6.33K
Sale
ScheduledJun 14
Form 4
16.48%
1.30K
Jun 13, 2013
9.23K
Grant
Jun 12
Form 4
$53.43
$160.29K
May 31, 2013
7.92K
Options
ScheduledMay 29
Form 4
-82.74%
-37.98K
$147.00
-$7.11M
May 29, 2013
7.92K
Sale
ScheduledMay 28
Form 4
-61.86%
-7.98K
$148.62
-$1.19M
Dec 28, 2012
4.92K
Sale
ScheduledDec 26 - Dec 27
Form 4
18.57%
2.02K
Jun 11, 2012
12.90K
Grant
Jun 08
Form 4
36.71%
2.90K
Jun 03, 2011
10.80K
Grant
Jun 01
Form 4
255.46%
5.74K
Jun 11, 2010
7.98K
Grant
Jun 09
Form 4
43.22K
Jun 12, 2009
43.22K
Grant
Jun 10
Form 3
Jun 12, 2009
Showing 26 results

IRONWOOD PHARMACEUTICALS INC

Investor
Updated Sep 18, 2024
Form 4
2.21%
3.28K
Sep 18, 2024
16.54M
Grant
Sep 16
Form 4
19.53%
24.31K
Jun 21, 2024
16.54M
Grant
Jun 18
Form 4
2.11%
2.57K
Jun 18, 2024
16.51M
Grant
Jun 15
Form 4
1.38%
1.66K
Mar 19, 2024
16.51M
Grant
Mar 15
Form 4
1.13%
1.35K
Dec 19, 2023
16.51M
Grant
Dec 15
Form 4
1.54%
1.80K
Sep 19, 2023
16.51M
Grant
Sep 15
Form 4
23.58%
22.35K
Jun 22, 2023
16.51M
Grant
Jun 20
Form 4
1.45%
1.36K
Jun 20, 2023
16.48M
Grant
Jun 15
Form 4
1.56%
1.44K
Mar 17, 2023
16.48M
Grant
Mar 15
Form 4
1.37%
1.24K
Dec 19, 2022
16.48M
Grant
Dec 15
Form 4
1.54%
1.37K
Sep 19, 2022
16.48M
Grant
Sep 15
Form 4
1.39%
1.22K
Jun 17, 2022
16.48M
Grant
Jun 15
Form 4
32.40%
21.57K
Jun 03, 2022
16.48M
Grant
Jun 01
Form 4
1.76%
1.15K
Mar 17, 2022
16.46M
Grant
Mar 15
Form 4
1.89%
1.21K
Dec 17, 2021
16.46M
Grant
Dec 15
Form 4
1.80%
1.14K
Sep 17, 2021
16.45M
Grant
Sep 15
Form 4
1.99%
1.23K
Jun 16, 2021
16.45M
Grant
Jun 15
Form 4
58.26%
22.77K
Jun 04, 2021
16.45M
Grant
Jun 02
Form 4
3.26%
1.24K
Mar 17, 2021
16.43M
Grant
Mar 15
Form 4
1.39%
225.00K
$10.38
$2.34M
Mar 10, 2021
16.43M
Purchase
Mar 08 - Mar 10
Form 4
5.04%
775.00K
$10.01
$7.76M
Mar 05, 2021
16.20M
Purchase
Mar 03 - Mar 05
Form 4
9.62%
1.35M
$9.44
$12.74M
Mar 02, 2021
15.43M
Purchase
Feb 26 - Mar 02
Form 4
1.78%
661.00
Dec 17, 2020
14.08M
Grant
Dec 15
Form 4
37.18K
Nov 09, 2020
14.08M
Grant
Nov 09
Form 3
Nov 09, 2020
14.04M
Showing 25 results

Sarissa Capital Acquisition Corp.

Investor
Updated Nov 03, 2020
Form 4
-0.62%
-31.25K
Nov 03, 2020
5.00M
Disposition
Oct 30
Form 4
3.33M
$1.50
$5.00M
Oct 23, 2020
3.33M
Purchase
Oct 23
Form 3
Oct 20, 2020
Showing 3 results

ENZON PHARMACEUTICALS INC

Investor
Updated Jan 04, 2013
Form 4
40.26K
Jan 04, 2013
40.26K
Grant
Jan 02
Form 4
54.32%
21.34K
Jul 03, 2012
60.62K
Grant
Jul 02
Form 4
21.99K
Jan 05, 2012
21.99K
Grant
Jan 03
Form 4
60.22%
14.76K
Jul 06, 2011
39.28K
Grant
Jul 01
Form 4
33.99K
Jan 05, 2011
33.99K
Grant
Jan 03
Form 4
135.03%
14.09K
Jul 06, 2010
24.52K
Grant
Jul 01
Form 4
33.57K
Jan 06, 2010
33.57K
Grant
Jan 04
Form 4
36.32K
May 26, 2009
36.32K
Grant
May 21
Form 3
May 26, 2009
Showing 9 results

Iterum Therapeutics plc

Investor
Updated Feb 12, 2021
Form 4
-42.11%
-15.00M
$2.43
-$50.01M
Feb 12, 2021
20.62M
Sale
Feb 11 - Feb 12
Form 3
Nov 23, 2020
Showing 2 results

ADVENTRX PHARMACEUTICALS INC

Investor
Updated Oct 19, 2009
Form 4
Oct 19, 2009
Form 4
50.00%
50.00K
Jul 08, 2008
150.00K
Grant
Jun 30
Form 4
100.00%
50.00K
Mar 26, 2008
100.00K
Grant
Mar 24
Form 4
50.00K
May 25, 2007
50.00K
Grant
May 23
Form 3
Oct 26, 2006
Showing 5 results

APRICUS BIOSCIENCES, INC.

Investor
Updated Mar 23, 2018
Form 4
Mar 23, 2018
653.41K
Acq/Dis
Mar 21
Form 4
0.42%
8.94K
$1.63
$9.95K
Sep 01, 2017
2.12M
Purchase
Aug 31
Form 4
88.78%
9.97M
$0.88
$5.85M
Mar 07, 2016
21.20M
Purchase
Mar 03
Form 4
21.14%
1.96M
$0.88
$1.15M
Jan 14, 2016
11.23M
Purchase
Jan 12
Form 3
Feb 23, 2015
6.52M
Showing 5 results

Regulus Therapeutics Inc.

Investor
Updated Jan 03, 2020
Form 4
251.36%
4.65M
Jan 03, 2020
6.51M
Purchase
Dec 24
Form 3
May 17, 2019
1.85M
Showing 2 results

Bioverativ Inc.

Investor
Updated Mar 08, 2018
Form 4
-100.00%
-1.20M
Mar 08, 2018
Disposition
Mar 08
Form 4
5.46K
Feb 02, 2018
5.46K
Grant
Jan 31
Form 4
0.08%
932.00
$56.69
$52.84K
Aug 31, 2017
1.17M
Grant
Aug 31
Form 4
8.37%
90.00K
$55.93
$5.03M
Jun 01, 2017
1.17M
Purchase
May 30
Form 4
593.55%
920.00K
$55.77
$51.31M
May 26, 2017
1.08M
Purchase
May 24 - May 26
Form 4
26.77%
1.06K
$56.83
$60.01K
Apr 17, 2017
160.00K
Grant
Apr 17
Form 4/A
26.82K
Mar 27, 2017
26.82K
Grant
Feb 14
Form 4
26.77K
Feb 16, 2017
26.77K
Grant
Feb 14
Form 3
Jan 19, 2017
Showing 9 results

Innoviva, Inc.

Investor
Updated Jun 20, 2023
Form 4
0.86%
62.00K
$13.13
$814.20K
Jun 20, 2023
7.28M
Purchase
Jun 15
Form 4
0.21%
15.00K
$13.05
$195.68K
Jun 07, 2023
7.22M
Purchase
Jun 05 - Jun 06
Form 4
2.86%
200.00K
$13.04
$2.61M
May 30, 2023
7.20M
Purchase
May 25 - May 30
Form 4/A
1.39%
96.00K
$13.22
$1.27M
May 19, 2023
7.00M
Purchase
May 17 - May 19
Form 4
0.87%
60.00K
$13.07
$784.23K
May 19, 2023
6.96M
Purchase
May 17 - May 18
Form 4
4.38%
290.00K
$12.34
$3.58M
May 15, 2023
6.90M
Purchase
May 11
Form 3
May 15, 2023
6.61M
Showing 7 results

ARIAD PHARMACEUTICALS INC

Investor
Updated Feb 16, 2017
Form 4
-100.00%
-21.85M
Feb 16, 2017
Disposition
Feb 16
Form 4
122.30%
43.01K
$23.82
$595.50K
Feb 02, 2017
12.93M
Grant
Jan 31
Form 4
165.45%
37.50K
$4.91
$122.75K
Feb 03, 2016
12.91M
Grant
Feb 01
Form 4
47.66K
$6.45
$161.25K
Feb 04, 2015
12.90M
Grant
Jan 31
Form 4
80.42%
9.65M
$3.39
$13.24M
Aug 19, 2014
21.65M
Purchase
Aug 15 - Aug 18
Form 4
75.00K
Feb 24, 2014
75.00K
Grant
Feb 20
Form 3
Feb 24, 2014
12.00M
Showing 7 results

AMYLIN PHARMACEUTICALS INC

Investor
Updated Aug 10, 2012
Form 4
-100.00%
-100.16K
$31.00
-$3.10M
Aug 10, 2012
Disposition
Aug 08
Form 4
321.18%
23.00K
May 17, 2012
30.16K
Grant
May 15
Form 4
-20.37%
-1.83K
$11.59
-$21.24K
Jan 19, 2012
7.16K
Sale
Jan 17
Form 4
48.04%
1.94K
$10.28
$19.99K
Oct 14, 2011
5.99K
Grant
Oct 12
Form 4
58.05%
1.49K
$13.45
$20.00K
Jul 08, 2011
4.05K
Grant
Jul 06
Form 4
23.00K
May 26, 2011
23.00K
Grant
May 24
Form 4
131.99%
1.46K
$11.15
$16.25K
Apr 06, 2011
2.56K
Grant
Apr 04
Form 4
1.10K
$14.72
$16.25K
Jan 11, 2011
1.10K
Grant
Jan 05
Form 4
20.00K
May 03, 2010
20.00K
Grant
Apr 29
Form 4
30.00K
Jun 11, 2009
30.00K
Grant
Jun 09
Form 3
Jun 11, 2009
Showing 11 results

VIVUS INC

Investor
Updated Nov 03, 2015
Form 4
25.00K
Nov 03, 2015
25.00K
Grant
Oct 30
Form 4
25.00K
May 29, 2015
25.00K
Grant
May 27
Form 4
28.24%
566.84K
$8.59
$4.87M
Nov 12, 2013
2.57M
Purchase
Nov 08 - Nov 11
Form 4
25.00K
Aug 16, 2013
25.00K
Grant
Aug 14
Form 4
Jul 23, 2013
2.01M
Form 3
Jun 03, 2013
2.01M
Showing 6 results

MEDICINES CO /DE

Investor
Updated Jan 06, 2020
Form 4
-100.00%
-4.36M
Jan 06, 2020
Disposition
Jan 06
Form 4
1.20%
50.00K
$33.00
$1.65M
Jun 28, 2019
4.22M
Purchase
Jun 28
Form 4
163.71%
17.07K
Jun 03, 2019
4.18M
Grant
May 30
Form 4
2.09%
85.00K
$34.83
$2.96M
May 31, 2019
4.15M
Purchase
May 29 - May 30
Form 4
11.85%
431.00K
$33.89
$14.61M
May 22, 2019
4.07M
Purchase
May 20 - May 22
Form 4
7.32%
248.10K
$24.91
$6.18M
Mar 08, 2019
3.64M
Purchase
Mar 06
Form 4
21.82%
606.90K
$25.59
$15.53M
Mar 05, 2019
3.39M
Purchase
Mar 01 - Mar 05
Form 4
0.36%
10.00K
$17.89
$178.90K
Dec 21, 2018
2.78M
Purchase
Dec 20
Form 4
30.06%
823.84K
$21.60
$20.54M
Dec 18, 2018
3.58M
Purchase
Dec 17 - Dec 18
Form 4
42.61%
819.00K
$20.26
$16.59M
Dec 17, 2018
2.75M
Purchase
Dec 13 - Dec 14
Form 4
193.71%
12.91K
Jun 04, 2018
1.94M
Grant
May 31
Form 4
9.70%
170.00K
$30.03
$5.11M
Nov 30, 2017
1.93M
Purchase
Nov 29
Form 4
0.41%
7.15K
$36.69
$262.19K
Aug 31, 2017
1.76M
Grant
Aug 31
Form 4
344.83%
11.81K
May 30, 2017
1.77M
Grant
May 25
Form 4
13.13K
May 31, 2016
1.77M
Grant
May 26
Form 4
27.23K
Feb 04, 2016
27.23K
Grant
Feb 02
Form 3
Feb 04, 2016
1.75M
Showing 17 results

IMCLONE SYSTEMS INC

Investor
Updated Nov 25, 2008
Form 4
Nov 25, 2008
Form 3/A
May 18, 2006
Form 4
-33.31K
May 05, 2006
Grant
May 02
Form 3
May 05, 2006
3.23M
Showing 4 results